Q98120440
proposition in the Riksdag 2018
Press Enter · cited answer in seconds
0 sources
Q98120440
Summary
Q98120440 is a bill[1].
Key Facts
- Q98120440's instance of is recorded as bill[2].
- Q98120440's part of the series is recorded as propositions of the 2017-2018 legislative session of the Riksdag[3].
- Q98120440's language of work or name is recorded as Swedish[4].
- Q98120440's publication date is recorded as +2018-03-27T00:00:00Z[5].
- Q98120440's main subject is recorded as medication[6].
- Q98120440's work available at URL is recorded as http://data.riksdagen.se/dokument/H503196[7].
- Q98120440's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H503196[8].
- Q98120440's work available at URL is recorded as http://data.riksdagen.se/fil/B7CBE440-F5A2-431C-88BB-03520457259D[9].
- Q98120440's applies to jurisdiction is recorded as Sweden[10].
- Q98120440's legal citation of this text is recorded as Prop. 2017/18:196[11].
- Q98120440's title is recorded as Anpassningar av svensk rätt till EU-förordningen om kliniska läkemedelsprövningar[12].
- Q98120440's signatory is recorded as Stefan Löfven[13].
- Q98120440's signatory is recorded as Annika Strandhäll[14].
- Q98120440's cites work is recorded as Q98120570[15].
- Q98120440's cites work is recorded as Q98120518[16].
- Q98120440's cites work is recorded as Q98120633[17].
- Q98120440's cites work is recorded as Q98120601[18].
- Q98120440's cites work is recorded as Q98120587[19].
- Q98120440's cites work is recorded as Q98120660[20].
- Q98120440's cites work is recorded as Q98138893[21].
- Q98120440's cites work is recorded as Q98127893[22].
- Q98120440's cites work is recorded as Q98138995[23].
- Q98120440's cites work is recorded as Q98138704[24].
- Q98120440's cites work is recorded as Q98130144[25].
- Q98120440's cites work is recorded as Q98120582[26].